Member Info for bluemoonpattaya

An interesting read for a new investor to this share.
It is more of a view of the company's that are around us, and what they are working on. https://stockhead.com.au/resources/these-small-caps-are-chasing-elephants-in-the-paterson/

Maybe Novacyt have some extra product, that needs shifting

Account ManagAccount Manager – Food, Industry & Distribution Sales Field Based (with nationwide travel)
https://www.reed.co.uk/jobs/novacyt/p72307?keywords=Manager&sortby=DisplayDate

NO

Yes the spread has gone down. But i was just wondering the significance in general of having a larger spread.
Just trying to learning how the markets work.

Big spread of 15p . What are they up to ?

now up 32%....................................... when it is 1000 % up i will take notice

That's the RNS for the lab test, the next RNS should be for the point of care test. looking good

Antigen test for me is the most important, then antibody.
"At this moment, the priority is to test healthcare workers and those patients requiring hospitalisation for the presence of SARS-CoV-2 using the antigen test"
https://www.abpi.org.uk/medicine-discovery/covid-19/what-is-the-life-sciences-sector-doing-to-help-increase-covid-19-testing/

He should now be called....... Major Tom

Motif is granting Hercules warrants over 121.3mln shares – roughly 25% of Motif’s issued share capital – that will expire on 27 January 2025 if not exercised before then at 0.42p a share.

Several former directors have agreed to take options over shares in lieu of outstanding board fees. In total, options over 1.2mln shares will be granted, with an exercise price of 0.24p per share.

Will £3 trigger a few automatic sells...

maybe it will get a mention on the government daily briefing. but not before a few portfolios have been filled.

If that's the possible lock down period the government are talking about. Then the 7 weeks we have to wait, is not that long
RNS 25th March ,
"The Company anticipates that a clinically validated high throughput test format could be available in approximately eight weeks"

LAST FIVE PUBLISHED TRADES
Time/date of execution Price Currency Volume Trade value* Trade type Trade flags MIC
16:32:45 25-Mar-2020 32.50 GBX 50,000 16,250.00 Off-book LRGS AIMX
16:28:16 25-Mar-2020 29.00 GBX 54,978 15,943.62 Off-book LRGS AIMX
16:28:13 25-Mar-2020 29.00 GBX 48,891 14,178.39 Off-book LRGS AIMX
16:25:36 25-Mar-2020 30.00 GBX 49,955 14,986.50 Off-book LRGS AIMX
16:26:09 25-Mar-2020 30.00 GBX 33,306 9,991.80 Off-book LRGS AIMX

Only 40% of shares available= about 14,000,000 shares

Substantial holdings Shares held %
Calculus Capital 6,588,032 18.9% *
Spreadex Ltd 4,409,783 12.65%
BGF Investment Management Limited 4,347,826 12.8% *
Odey Asset Management 1,880,266 5.5% *
River & Mercantile Asset Management 1,819,957 5.4% *

Directors and related shareholders
Ian Gilham 490,674 1.4%
David Budd 188,710 0.5%
Matthew Fowler 86,957 0.3%
Tom Lindsay 190,217 0.5%
Chris Yates 41,304 0.1%
Total Directors' holdings 997,862 2.9%

Total shares in issue 34,870,071 100.00%

With only 35,000,000 in circulation.

10,000 tests per hour, and thus this could be both a material revenue generator for the Company and significant contributor to addressing the global pandemic. Freeze dried assays require no refrigeration and are stable in transport, which is a significant logistical advantage for rapid shipment and global distribution.
Sounds good to me

with the increase in world wide coronovirus infection, we are at the start of huge rise of infections as the curve rises higher
CF you could help save the world and help to flatten this curve, as you are the master...

A nice engulfing candle on the crude day chart.
let's see if this is a possible reversal signal, or if the panic will continue.